ReviewJAC-antimicrobial resistance2025
Nurse prescribing for selected UTIs in Spain: a challenging step forward.
Review in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper examines the implications of Spain's recent legislative reform enabling nurses to prescribe antibiotics for uncomplicated urinary tract infections (UTIs) in women, positioning it as a critical development in antimicrobial stewardship (AMS) and nursing practice. The paper aims to assess how this policy aligns with international models of nurse prescribing, evaluating its potential to enhance workforce flexibility, and identifying some challenges and opportunities regarding its implementation. While this reform may reduce pressures on general practitioners and optimize primary care delivery, it raises questions regarding diagnostic accuracy, restricted formularies and the need for rigorous surveillance. The viewpoint highlights the importance of robust training in diagnostic and clinical reasoning, regular updates to antibiotic formularies and comprehensive auditing mechanisms to ensure safe and effective prescribing. Additionally, we explore broader considerations, such as professional incentives and inter-professional collaboration, essential for the sustained impact of nurse prescribing. By centring the discussion on nursing leadership in AMS, we highlight an underexplored area of policy implementation, with implications for other countries considering similar reforms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.